1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Brubaker, K.
Cowley, S.M.
Huang, K.
Eisenman, R.N.
Radhakrishnan, I.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Cell(Cambridge,Mass.)
CELLB5
0998
0092-8674
103
655
665
10.1016/S0092-8674(00)00168-9
11106735
Solution structure of the interacting domains of the Mad-Sin3 complex: implications for recruitment of a chromatin-modifying complex.
2000
10.2210/pdb1g1e/pdb
pdb_00001g1e
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1968.302
MAD1 PROTEIN
SIN3 INTERACTION DOMAIN (SID) TRANSREPRESSION DOMAIN
1
syn
polymer
10343.438
SIN3A
PAIRED AMPHIPATHIC HELIX 2 (PAH2 REPEAT)
1
man
polymer
MAX DIMERIZATION PROTEIN
no
no
RMNIQMLLEAADYLER
RMNIQMLLEAADYLER
A
polypeptide(L)
no
no
SLQNNQPVEFNHAINYVNKIKNRFQGQPDIYKAFLEILHTYQKEQRNAKEAGGNYTPALTEQEVYAQVARLFKNQEDLLS
EFGQFLPDA
SLQNNQPVEFNHAINYVNKIKNRFQGQPDIYKAFLEILHTYQKEQRNAKEAGGNYTPALTEQEVYAQVARLFKNQEDLLS
EFGQFLPDA
B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
house mouse
Mus
Escherichia
sample
10090
Mus musculus
562
Escherichia coli
PET24
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2000-12-06
1
1
2008-04-27
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
RCSB
Y
RCSB
2000-10-11
REL
REL
The peptide sequence was synthesized via automated methods. The sequence is naturally found in Homo sapiens (human).
sample
Interproton NOEs were assigned iteratively but manually during structure refinement.
structures with favorable non-bond energy,structures with the least restraint violations
25
15
3D 15N-separated_NOESY
HNHA
2D 13C,15N-double-half-filtered NOESY
2D 13C-double-half-filtered NOESY
3D 13C-separated_NOESY
3D HACAHB
2D Spin-echo Difference for JNCgamma, JC'Cgamma
3D HNHB
20 mM phosphate
6.0
ambient
300
K
The structures are based on 1612 unique distance constraints, 198 torsion angle constraints and 72 JHNHA coupling constant constraints.
distance geometry, simulated annealing
15
minimized average structure
1.0 mM 1:1 SID unlabeled, PAH2 U-15N; 1.6 mM 1:1 SID unlabeled, PAH2 U-15N, U-13C.
90% H2O/10% D2O
1.6 mM 1:1 SID unlabeled, PAH2 U-15N,13C; 20 mM phosphate buffer pH 6.0, 0.2% NaN3
90% H2O/10% D2O
1.6 mM 1:1 SID unlabeled, PAH2 U-15N,13C; 20 mM phosphate buffer pH 6.0, 0.2% NaN3
100% D2O
Molecular Simulations
processing
Felix
98
Molecular Simulations
data analysis
Felix
98
Guntert, Wuthrich
structure solution
DYANA
1.5
Brunger
refinement
CNS
1.0
600
Varian
INOVA
500
Varian
INOVA
ARG
6
n
1
ARG
6
A
MET
7
n
2
MET
7
A
ASN
8
n
3
ASN
8
A
ILE
9
n
4
ILE
9
A
GLN
10
n
5
GLN
10
A
MET
11
n
6
MET
11
A
LEU
12
n
7
LEU
12
A
LEU
13
n
8
LEU
13
A
GLU
14
n
9
GLU
14
A
ALA
15
n
10
ALA
15
A
ALA
16
n
11
ALA
16
A
ASP
17
n
12
ASP
17
A
TYR
18
n
13
TYR
18
A
LEU
19
n
14
LEU
19
A
GLU
20
n
15
GLU
20
A
ARG
21
n
16
ARG
21
A
SER
295
n
1
SER
295
B
LEU
296
n
2
LEU
296
B
GLN
297
n
3
GLN
297
B
ASN
298
n
4
ASN
298
B
ASN
299
n
5
ASN
299
B
GLN
300
n
6
GLN
300
B
PRO
301
n
7
PRO
301
B
VAL
302
n
8
VAL
302
B
GLU
303
n
9
GLU
303
B
PHE
304
n
10
PHE
304
B
ASN
305
n
11
ASN
305
B
HIS
306
n
12
HIS
306
B
ALA
307
n
13
ALA
307
B
ILE
308
n
14
ILE
308
B
ASN
309
n
15
ASN
309
B
TYR
310
n
16
TYR
310
B
VAL
311
n
17
VAL
311
B
ASN
312
n
18
ASN
312
B
LYS
313
n
19
LYS
313
B
ILE
314
n
20
ILE
314
B
LYS
315
n
21
LYS
315
B
ASN
316
n
22
ASN
316
B
ARG
317
n
23
ARG
317
B
PHE
318
n
24
PHE
318
B
GLN
319
n
25
GLN
319
B
GLY
320
n
26
GLY
320
B
GLN
321
n
27
GLN
321
B
PRO
322
n
28
PRO
322
B
ASP
323
n
29
ASP
323
B
ILE
324
n
30
ILE
324
B
TYR
325
n
31
TYR
325
B
LYS
326
n
32
LYS
326
B
ALA
327
n
33
ALA
327
B
PHE
328
n
34
PHE
328
B
LEU
329
n
35
LEU
329
B
GLU
330
n
36
GLU
330
B
ILE
331
n
37
ILE
331
B
LEU
332
n
38
LEU
332
B
HIS
333
n
39
HIS
333
B
THR
334
n
40
THR
334
B
TYR
335
n
41
TYR
335
B
GLN
336
n
42
GLN
336
B
LYS
337
n
43
LYS
337
B
GLU
338
n
44
GLU
338
B
GLN
339
n
45
GLN
339
B
ARG
340
n
46
ARG
340
B
ASN
341
n
47
ASN
341
B
ALA
342
n
48
ALA
342
B
LYS
343
n
49
LYS
343
B
GLU
344
n
50
GLU
344
B
ALA
345
n
51
ALA
345
B
GLY
346
n
52
GLY
346
B
GLY
347
n
53
GLY
347
B
ASN
348
n
54
ASN
348
B
TYR
349
n
55
TYR
349
B
THR
350
n
56
THR
350
B
PRO
351
n
57
PRO
351
B
ALA
352
n
58
ALA
352
B
LEU
353
n
59
LEU
353
B
THR
354
n
60
THR
354
B
GLU
355
n
61
GLU
355
B
GLN
356
n
62
GLN
356
B
GLU
357
n
63
GLU
357
B
VAL
358
n
64
VAL
358
B
TYR
359
n
65
TYR
359
B
ALA
360
n
66
ALA
360
B
GLN
361
n
67
GLN
361
B
VAL
362
n
68
VAL
362
B
ALA
363
n
69
ALA
363
B
ARG
364
n
70
ARG
364
B
LEU
365
n
71
LEU
365
B
PHE
366
n
72
PHE
366
B
LYS
367
n
73
LYS
367
B
ASN
368
n
74
ASN
368
B
GLN
369
n
75
GLN
369
B
GLU
370
n
76
GLU
370
B
ASP
371
n
77
ASP
371
B
LEU
372
n
78
LEU
372
B
LEU
373
n
79
LEU
373
B
SER
374
n
80
SER
374
B
GLU
375
n
81
GLU
375
B
PHE
376
n
82
PHE
376
B
GLY
377
n
83
GLY
377
B
GLN
378
n
84
GLN
378
B
PHE
379
n
85
PHE
379
B
LEU
380
n
86
LEU
380
B
PRO
381
n
87
PRO
381
B
ASP
382
n
88
ASP
382
B
ALA
383
n
89
ALA
383
B
author_defined_assembly
2
dimeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
A
O
H
MET
MET
7
11
1.57
4
B
B
HH
O
TYR
LEU
310
372
1.59
9
B
B
O
H
VAL
LYS
311
315
1.59
9
A
A
O
H
ILE
LEU
9
13
1.60
14
B
B
O
H
VAL
LYS
311
315
1.60
2
-3.78
0.60
121.00
117.22
A
A
A
CB
CG
CD2
TYR
TYR
TYR
18
18
18
N
1
A
ASN
8
-7.09
-97.36
1
B
GLN
300
57.06
85.71
1
B
PHE
318
-98.93
39.85
1
B
PHE
366
-90.38
43.98
1
B
LYS
367
-51.70
-74.32
1
B
GLN
369
-142.44
49.40
1
B
ASP
382
-87.73
48.61
2
A
MET
7
65.37
-179.82
2
A
ASN
8
-84.33
-73.10
2
B
LEU
296
65.18
89.53
2
B
GLN
297
72.95
154.99
2
B
ASN
298
67.31
152.79
2
B
ASN
299
46.49
-168.84
2
B
GLN
300
63.33
86.16
2
B
PHE
318
-102.24
41.22
2
B
GLN
321
-105.24
79.26
2
B
PHE
366
-88.61
42.53
2
B
GLN
369
-142.40
52.40
2
B
PRO
381
-64.51
-159.66
3
A
ASN
8
-126.67
-53.63
3
B
GLN
297
76.54
-82.76
3
B
ASN
298
-150.91
-26.96
3
B
ASN
348
-83.43
33.68
3
B
PRO
381
-68.81
7.46
3
B
ASP
382
-89.63
31.61
4
A
ASN
8
-176.02
-127.16
4
B
ASN
298
-88.13
-78.46
4
B
THR
350
66.89
127.56
4
B
PHE
366
-91.56
41.81
4
B
LYS
367
-49.64
-71.76
4
B
ASN
368
-85.19
33.89
4
B
PRO
381
-56.81
-155.33
5
A
ASN
8
-147.83
-119.01
5
B
LEU
296
61.68
99.39
5
B
GLN
321
-103.87
79.34
5
B
ASN
348
-83.90
32.66
5
B
PHE
366
-88.40
-141.39
5
B
LYS
367
113.69
-52.27
5
B
GLN
369
-142.31
58.16
5
B
PRO
381
-59.44
19.97
5
B
ASP
382
67.51
-79.96
6
A
MET
7
76.21
-20.26
6
B
ASN
298
-149.81
-28.93
6
B
GLN
300
68.86
137.90
6
B
PHE
318
-96.99
38.46
6
B
PHE
366
-90.53
41.03
6
B
GLN
369
-142.72
53.38
6
B
PRO
381
-62.36
-156.90
7
A
ASN
8
-172.48
-129.95
7
B
GLN
297
53.88
-170.58
7
B
ASN
298
63.71
179.93
7
B
ASN
299
-77.67
-166.36
7
B
GLN
300
70.61
82.41
7
B
PHE
318
-101.91
42.46
7
B
GLN
321
-107.16
78.80
7
B
TYR
349
-157.47
-51.26
7
B
THR
350
61.91
131.27
7
B
PHE
366
-90.33
32.29
7
B
GLN
369
-142.37
58.95
7
B
PRO
381
-66.05
12.39
8
A
MET
7
68.23
99.60
8
A
ASN
8
-84.73
-124.62
8
B
GLN
297
-162.61
-45.64
8
B
ASN
298
71.39
-73.44
8
B
ASN
299
-159.09
-124.76
8
B
PRO
301
-83.76
36.29
8
B
PHE
318
-100.84
44.97
8
B
ASN
348
-156.59
-47.74
8
B
PHE
366
-90.99
51.43
8
B
LYS
367
-51.96
-75.55
8
B
ASN
368
-85.13
38.55
8
B
GLN
369
-149.93
56.43
8
B
PRO
381
-64.27
-159.10
9
A
ASN
8
-103.44
-66.35
9
B
GLN
300
67.03
156.97
9
B
PHE
318
-99.60
39.57
9
B
THR
350
64.04
132.54
9
B
PHE
366
-94.89
36.26
9
B
GLN
369
-142.70
48.90
9
B
PRO
381
-74.66
-150.53
10
B
LEU
296
-163.95
-52.13
10
B
GLN
297
-162.73
-55.68
10
B
ASN
298
60.77
95.14
10
B
PHE
318
-99.54
33.80
10
B
GLN
321
-105.97
75.84
10
B
PHE
366
-88.62
47.94
10
B
LYS
367
-50.86
-73.31
10
B
GLN
369
-142.34
50.26
10
B
PRO
381
-34.85
156.33
11
A
ASN
8
-171.23
-95.14
11
B
LEU
296
62.95
93.52
11
B
ASN
298
-88.07
-78.64
11
B
GLN
300
60.77
84.51
11
B
PHE
318
-101.10
46.35
11
B
GLN
321
-119.92
75.65
11
B
ASN
348
-83.25
34.26
11
B
TYR
349
-163.23
117.93
11
B
PHE
366
-89.66
44.25
11
B
GLN
369
-142.48
53.76
11
B
PRO
381
-63.03
-158.80
12
A
ILE
9
60.39
-59.17
12
B
ASN
298
61.43
79.06
12
B
PHE
318
-95.54
31.64
12
B
TYR
349
-157.27
-60.19
12
B
THR
350
61.94
133.48
12
B
PHE
366
-89.20
47.09
12
B
GLN
369
-142.42
47.50
13
A
ASN
8
-135.70
-51.73
13
B
GLN
297
84.87
-34.25
13
B
ASN
298
69.54
133.12
13
B
GLN
300
-154.76
81.10
13
B
PHE
318
-99.62
37.03
13
B
ASN
348
-156.67
-92.39
13
B
TYR
349
34.17
-74.50
13
B
THR
350
78.72
128.48
13
B
PHE
366
-88.45
47.84
13
B
GLN
369
-142.31
51.06
13
B
PRO
381
-68.83
-158.72
14
A
MET
7
-110.54
-140.87
14
B
TYR
349
-157.49
-65.67
14
B
THR
350
64.88
134.41
14
B
LYS
367
-51.75
-79.78
14
B
ASN
368
-82.87
38.81
14
B
GLN
369
-149.89
49.42
15
A
ASN
8
-123.42
-58.74
15
B
GLN
297
-163.74
-25.47
15
B
ASN
299
38.09
77.58
15
B
GLN
300
47.27
167.97
15
B
PHE
366
-88.80
48.41
15
B
GLN
369
-142.46
53.57
15
B
PRO
381
-76.00
-79.28
minimized average
NMR STRUCTURE OF THE HUMAN MAD1 TRANSREPRESSION DOMAIN SID IN COMPLEX WITH MAMMALIAN SIN3A PAH2 DOMAIN
1
N
N
2
N
N
A
ILE
9
A
ILE
4
HELX_P
A
GLU
20
A
GLU
15
1
1
12
B
VAL
302
B
VAL
8
HELX_P
B
ARG
317
B
ARG
23
1
2
16
B
PRO
322
B
PRO
28
HELX_P
B
ALA
345
B
ALA
51
1
3
24
B
GLU
355
B
GLU
61
HELX_P
B
LEU
365
B
LEU
71
1
4
11
B
GLU
370
B
GLU
76
HELX_P
B
GLY
377
B
GLY
83
1
5
8
TRANSCRIPTION
Four-helix bundle, Protein-peptide Complex, TRANSCRIPTION
NP_002348
GB
1
6
4505069
RMNIQMLLEAADYLER
SIN3A_MOUSE
UNP
2
295
Q60520
SLQNNQPVEFNHAINYVNKIKNRFQGQPDIYKAFLEILHTYQKEQRNAKEAGGNYTPALTEQEVYAQVARLFKNQEDLLS
EFGQFLPDA
6
21
1G1E
6
21
4505069
A
1
1
16
295
383
1G1E
295
383
Q60520
B
2
1
89
1
P 1